JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, J. R.
Right arrow Articles by Hallworth, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, J. R.
Right arrow Articles by Hallworth, S. P.
Related Collections
Right arrow Obstetrics
Right arrow Coagulation
Right arrow Monitoring (Non-cardiac)

Anesth Analg 2007;104:416-420
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000253510.00213.05

OBSTETRIC ANESTHESIA

Hemostatic Function in Healthy Pregnant and Preeclamptic Women: An Assessment Using the Platelet Function Analyzer (PFA-100®) and Thromboelastograph®

Jeremy R. Davies, FRCA, Roshan Fernando, FRCA, and Stephen P. Hallworth, FRCA

From the Department of Anesthetics, Royal Free Hospital, London, United Kingdom.

Address correspondence and reprint requests to Dr. Roshan Fernando, Department of Anesthesia, Royal Free Hospital, Pond St., London NW3 2QG, UK. Address e-mail to r.fernando{at}btinternet.com.

BACKGROUND: The PFA-100® is a point-of-care platelet function analyzer which measures the speed of formation of a platelet plug in vitro, expressed as closure time (CT) in seconds. This device could potentially be used to assess primary hemostasis prior to regional anesthesia. In this prospective, observational study we sought to establish 95% reference intervals for PFA-100 and Thromboelastograph® (TEG®) values for our normal pregnant population, before comparing the PFA and TEG in measuring platelet function in preeclamptic and healthy pregnant women at term, using confidence interval analysis and analysis of variance.

METHODS: Routine hematologic and coagulation tests were performed along with von Willebrand Factor, CT, and TEG measurements. Results are expressed as mean (sd).

RESULTS: Increased severity of preeclampsia was associated with increasing prolongation of CT, even in the presence of normal platelet counts. In severe preeclampsia, the PFA-100 CT (mean (sd): 155 (65) s) exceeded the 95% reference interval of the control group (70–139 s). In contrast, TEG maximum amplitude (MA) in severe preeclampsia (mean (sd): 71 (8) mm) remained within the 95% reference interval for MA in normal pregnancy (64–82 mm).

CONCLUSION: We conclude that impairment of primary hemostatic function with increasing severity of preeclampsia was recorded by the PFA-100 but not the TEG.




This article has been cited by other articles:


Home page
 Br J AnaesthHome page
R. E. Self and G. M. Howard-Alpe
Regional anaesthesia in patients treated with aspirin and clopidogrel
Br. J. Anaesth., October 1, 2007; 99(4): 594 - 596.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2007 by the International Anesthesia Research Society.